Edwards Lifesciences Investments Trend

EW -- USA Stock  

USD 153.90  1.03  0.67%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Investments of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Total Assets representing the total amount of marketable and non-marketable securties, loans receivable and other invested assets.
Investments10 Years Trend
Increasing
Slightly volatile
 Investments 
      Timeline 

Regression Statistics

Arithmetic Mean  454,003,644
Geometric Mean  217,109,560
Coefficient Of Variation  89.74
Mean Deviation  369,019,309
Median  301,100,000
Standard Deviation  407,401,169
Range  1,003,600,000
R Value  0.90
R Squared  0.81
Significance  0.00002462
Slope  94,380,682

Edwards Lifesciences Investments Over Time

2016-12-31  873,100,000 
2017-12-31  873,100,000 
2018-12-31  925,947,368 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Edwards Lifesciences Upcoming Company Events
Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.